Glycineamides
A process for the synthesis of N-aryl-3,4-dihydro-2-alkyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides by treatment of N-aryl-N'-alkyl-N'-(2'-alkoxycarbonylbenzenesulfonyl)glycineamides, useful intermediates for said process, with an alkali or alkaline earth metal hydride in a reaction-inert solvent at 50.degree.-150.degree. C., said products being antiinflammatory agents. .Iadd.
Latest Pfizer Inc. Patents:
This invention relates to a process for the synthesis of 1,2-benzothiazine-3-carboxamides, and in particular to the preparation of N-aryl-3,4-dihydro-2-alkyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides, a class of compounds useful as antiinflammatory agents, and to N-aryl-N'-alkyl-N'-(2'-alkoxycarbonylbenzenesulfonyl)glycineamides as useful intermediates for said process.
Synthesis of 3,4-dihydro-2-alkyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides has been previously achieved by amination of the corresponding 3-carboxylic acid ester or by treatment of the parent 3,4-dihydro-2-alkyl-4-oxo-2H-1,2-benzothiazine 1,1-dioxide with the appropriate isocyanate, Lombardino, et al., J. Med. Chem., 14, 1171 (1971) and Zinnes, et al., ibid., 16, 43 (1973) and U.S. Pat. No. 3,591,584. In addition, Zinnes, et al., loc. cit., has taught the preparation of 3-carboxamides by treatment of the pyrrolidine enamine of 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine 1,1-dioxide with phosgene followed by treatment of the resulting 3-carbonyl chloride with an appropriate amine.
U.S. Pat. No. 3,714,155 discloses 4-hydroxy-2,-N-dimethyl-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxides as antiinflammatory agents, synthesized by methylation of the corresponding N-phenyl carboxamide with dimethylsulfate in the presence of sodium hydride.
SUMMARY OF THE INVENTIONIt has now been discovered that preparation of compounds of the formula ##STR1## wherein R.sub.1 is selected from the group consisting of pheny; monosubstituted phenyl wherein said substituent is fluoro, chloro, methyl or methoxy; 2-thiazolyl; 4,5-dimethyl-2-thiazolyl; 2-pyridyl; 6-methyl-2-pyridyl; and 5-methyl-3-isoxazolyl; R.sub.2 is alkyl containing one to three carbon atoms; and X is a substituent selected from the group consisting of hydrogen, methyl, methoxy, fluoro, chloro and bromo, which comprises contacting a compound of the formula: ##STR2## wherein R.sub.3 is alkyl containing from 1 to 3 carbon atoms, with an alkali or alkaline earth metal hydride in a reaction-inert solvent at 50.degree.-150.degree. C. leads to the desired compounds which are potent nonsteroidal antiinflammatory agents.
Also claimed, as useful intermediates leading to the final products, are compounds of the formula ##STR3## wherein R.sub.1 is selected from the group consisting of phenyl; monosubstituted phenyl wherein said substituent is fluoro, chloro, methyl or methoxy; 2-thiazolyl; 4,5-dimethyl-2-thiazolyl; 2-pyridyl; 6-methyl-2-pyridyl; and 5-methyl-3-isoxazolyl; R.sub.2 is alkyl containing one to three carbon atoms; and X is a substituent selected from the group consisting of hydrogen, methyl, methoxy, fluoro, chloro and bromo.
Also considered within the scope of the instant invention is the process wherein R.sub.3 is alkyl of up to 8 carbon atoms, aryl or aralkyl, and wherein the metal hydride is replaced by a suitable organometallic reagent.
A preferred feature of the process leading to the compounds of the present invention is the use of sodium hydride as the metal hydride and tetrahydrofuran as the reaction-inert solvent, while the preferred intermediates are N-(aryl)-N'-methyl-N'-(2'-alkoxycarbonylbenzenesulfonyl)glycineamides.
DETAILED DESCRIPTION OF THE INVENTIONThe forementioned reaction is depicted in the following scheme ##STR4## wherein R.sub.1, R.sub.2, R.sub.3 and X are as previously described.
In the above reaction of the benzenesulfonylglycineamide with a metal hydride the ratio of reactants is two equivalents of hydride per mole of glycineamide. In practice, a slight excess of 5-10 percent over two equivalents of the metal hydride has no deleterious effect on the formation of the desired product.
It is also desirable to conduct said reaction in a reaction-inert solvent. By such a solvent, or mixtures thereof, is contemplated those, which under the conditions of the instant process, do not enter into appreciable reaction with either the starting reagents or products. It is preferred that non-aqueous, aprotic, polar solvents be employed. Suitable solvents or mixtures thereof which are included in this group are alicyclic ethers, di(lower)- alkoxyalkanes, di(lower)alkylsulfoxides, di(lower)alkyl(lower)alkanoic amides and hexa(lower)alkylphosphoramides. Favored solvents for the present process invention are tetrahydrofuran, dioxane, dimethylformamide and dimethylsulfoxide. The especially preferred solvent is tetrahydrofuran.
It is also preferred, although not a requirement, that the employed solvent be water-miscible.
Reaction time is not critical and in inherently dependent on concentration, reaction temperature and reactivity of the starting materials. In general, when temperatures of 50.degree.-100.degree. C. are employed, the reaction time will vary between 4-10 hours.
Regarding temperature range, it is preferred, for practical reasons, that the instantly claimed process be heated in order to obtain optimum yields of the desired products. A temperature range of 50.degree.-150.degree. C. is operative, with a preferred range of 50.degree.-100.degree. C.
At the conclusion of the cyclization reaction the mixture is cooled and added to water, to which is then added sufficient acid to render the mixture acidic to litmus paper. The product is then extracted with a water-immiscible solvent, such as methylene chloride or chloroform, and the organic extracts concentrated to dryness. Further purification of the product is effected by recrystallization from an appropriate solvent.
The intermediate benzenesulfonylglycineamides, which are cyclized under the conditions of the present process, are prepared as shown by the following flow diagram: ##STR5##
The glycine derivatives (1) are readily prepared by the methods reviewed by Greenstein and Winitz, "Chemistry of the Amino Acids," John Wiley & Sons, Inc., New York, New York 1961, Volumes 1-3.
As previously mentioned, the compounds of the present process invention are useful as antiinflammatory agents, and U.S. Pat. No. 3,591,584 teaches how to use these compounds for this utility. Of particular interest in the present invention are the synthesis of benzothiazine 1,1-dioxide wherein R.sub.2 is methyl, X is hydrogen and R.sub.1 is phenyl, 2-pyridyl, 2-thiazolyl or 6-methyl-2-pyridyl.
The particularly preferred benzenesulfonylglycineamide intermediates are those wherein R.sub.1 is phenyl, pyridyl, 2-thiazolyl or 6-methyl-2-pyridyl and R.sub.2 and R.sub.3 are each methyl.
The examples which follow are given by way of illustration, and are not to be construed as limitations of this invention, many variations of which are possible within the scope and spirit thereof.
EXAMPLE 1 N-(2-Thiazolyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxami de 1,1-dioxideTo 25 mg. (0.068 m mole) of N-(2-thiazolyl)-N'-methyl-N'-(2'-methoxycarbonylbenzenesulfonyl)-glycineam ide in 2 ml. of dry tetrahydrofuran maintained under a nitrogen atmosphere is added 6.5 mg. (0.135 m mole) of a 50% sodium hydride suspension in oil and the resulting reaction mixture heated under reflux overnight. The reaction mixture comprised of a yellow suspension is quenched with ice and subsequently acidified with 3N hydrochloric acid. The product is extracted with chloroform and the extracts combined and dried over sodium sulfate. The drying agent is filtered and the filtrate concentrated to a gum, which on trituration with 0.5 ml. of chloroform and 3 ml. of hexane yields 3.3 mg. of the desired product, m.p. 172.degree.-193.degree. C. Recrystallization, m.p. 256.degree. C. dec., provides material identical to that prepared in U.S. Pat. No. 3,591,584.
EXAMPLE 2 3,4-Dihydro-2-methyl-4-oxo-2H-1,2-benzothiazinecarboxanilide 1,1-dioxideTo a solution of 3.77 g. (0.01 mole) of N-phenyl-N'-methyl-N'-(2-ethoxycarbonylbenzenesulfonyl)-glycineamide in 40 ml. of dimethylformamide maintained under a nitrogen atmosphere is added portion-wise 960 mg. (0.02 mole) of a 50% sodium hydride suspension in oil, and the reaction mixture heated at steam bath temperatures for 6 hrs. The mixture is cooled, poured into ice and water and acidified with 6N hydrochloric acid. The product is extracted with chloroform and the combined chloroform extracts (3) are back-washed with water and dried over sodium sulfate. The solvent is removed under reduced pressure and the residue gum induced to crystallize by trituration with cold isopropanol. The filtered product proves to be identical with that reported in U.S. Pat. No. 3,591,584.
EXAMPLE 3 N-(6-Methyl-2-pyridyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-ca rboxamide 1,1-dioxideIn a manner similar to Examples 1 and 2, 2.03 g. (5 m moles) of N-(6-methyl-2-pyridyl)-N'-methyl-N'-(2'-propoxycarbonylbenzenesulfonyl)gly cineamide in 25 ml. of dioxane is treated with 205 mg. (5 m moles) calcium hydride and the resulting mixture heated under reflux overnight. The cooled reaction mixture is quenched in ice, acidified, and the product extracted with methylene chloride. The organic extracts are combined, dried over sodium sulfate and concentrated in vacuo to a gum. Trituration with cold acetonitrile followed by filtration provides the desired product.
EXAMPLE 4 3'-Chloro-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxideThe procedure of Example 1 is repeated, starting with 4.11 g. (0.01 mole) of N-(3-chlorophenyl)-N'-methyl-N'-(2-methoxycarbonylbenzenesulfonyl)-glyc ineamide and 800 mg. (0.02 mole) of a 50 percent suspension of potassium hydride in 40 ml. of dimethylsulfoxide, to yield the desired crude product. Further purification is achieved by recrystallization from acetic acid.
EXAMPLE 5The procedure of Example 1 is again repeated, starting with the appropriate N-aryl-N'-alkyl-N'-(2-methoxycarbonylbenzenesulfonyl)glycineamides to provide the following congeners:
______________________________________ ##STR6## X R.sub.1 R.sub.2 ______________________________________ 6-F C.sub.6 H.sub.5 CH.sub.3 6-F 3-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 6-F 4-CH.sub.3 OC.sub.6 H.sub.4 C.sub.2 H.sub.5 8-F 4-CH.sub.3 OC.sub.6 H.sub.4 CH.sub.3 8-F 4-ClC.sub.6 H.sub.4 C.sub.2 H.sub.5 8-F 6-CH.sub.3 -2-C.sub.5 H.sub.3 N n-C.sub.3 H.sub.7 6-Cl 3-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 6-Cl 2-C.sub.3 H.sub.2 NS n-C.sub.3 H.sub.7 6-Cl 3-FC.sub.6 H.sub.4 i-C.sub.3 H.sub.7 6-Cl 2-CH.sub.3 OC.sub.6 H.sub.4 i-C.sub.3 H.sub.7 7-Cl 2-C.sub.3 H.sub.2 NS CH.sub.3 7-Cl 2-C.sub.3 H.sub.2 NS C.sub.2 H.sub.5 7-Cl 2-C.sub.5 H.sub.4 N C.sub.2 H.sub.5 7-Cl 2-C.sub.6 H.sub.4 N i-C.sub.3 H.sub.7 7-Cl 2-C.sub.4 H.sub.3 O CH.sub.3 8-Cl C.sub.6 H.sub.5 CH.sub.3 5-CH.sub.3 C.sub.6 H.sub.5 CH.sub.3 5-CH.sub.3 4,5-(CH.sub.3).sub.2 C.sub.3 NS CH.sub.3 5-CH.sub.3 4,5-(CH.sub.3).sub.2 C.sub.3 NS n-C.sub.3 H.sub.7 5-CH.sub.3 4-ClC.sub.6 H.sub.4 C.sub.2 H.sub.5 7-Cl 5-CH.sub.3 -3-C.sub.3 HNO CH.sub.3 5-CH.sub.3 4-CH.sub.3 OC.sub.6 H.sub.4 CH.sub.3 6-CH.sub.3 2-C.sub.3 H.sub.2 NS CH.sub.3 6-CH.sub.3 2-C.sub.5 H.sub.4 N C.sub.2 H.sub.5 6-CH.sub.3 2-C.sub.4 H.sub.3 O CH.sub. 3 6-CH.sub.3 4-CH.sub.3 OC.sub.6 H.sub.4 CH.sub.3 6-CH.sub.3 2-C.sub.5 H.sub.4 N i-C.sub.3 H.sub.7 7-CH.sub.3 6-CH.sub.3 -2-C.sub.5 H.sub.3 N CH.sub.3 7-CH.sub.3 6-CH.sub.3 -2-C.sub.5 H.sub.3 N n-C.sub.3 H.sub.7 7-CH.sub.3 3-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 7-CH.sub.3 4,5-(CH.sub.3).sub.2 C.sub.3 NS CH.sub.3 7-CH.sub.3 C.sub.6 H.sub.5 C.sub.2 H.sub.5 6-CH.sub.3 O C.sub.6 H.sub.5 CH.sub.3 6-CH.sub.3 O C.sub.6 H.sub.5 C.sub.2 H.sub.5 6-CH.sub.3 O C.sub.6 H.sub.5 n-C.sub.3 H.sub.7 6-CH.sub.3 O 2-ClC.sub.6 H.sub.4 CH.sub.3 6-CH.sub.3 O 2-C.sub.4 H.sub.3 O CH.sub.3 7-CH.sub.3 O 3-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 7-CH.sub.3 O 2-C.sub.3 H.sub.2 NS n-C.sub.3 H.sub.7 7-CH.sub.3 O 2-C.sub.5 H.sub.4 N C.sub.2 H.sub.5 7-CH.sub.3 O 6-CH.sub.3 -2-C.sub.5 H.sub.3 N CH.sub.3 7-CH.sub.3 O 3-ClC.sub.6 H.sub.4 CH.sub.3 8-CH.sub.3 O C.sub.6 H.sub.5 CH.sub.3 8-CH.sub.3 O C.sub.6 H.sub.5 C.sub.2 H.sub.5 8-CH.sub.3 O 4-CH.sub.3 OC.sub.6 H.sub.4 CH.sub.3 8-CH.sub.3 O 4-ClC.sub.6 H.sub.4 CH.sub.3 6-CH.sub.3 5-CH.sub.3 -3-C.sub.3 HNO CH.sub.3 6-CH.sub.3 O 5-CH.sub.3 -3-C.sub.3 HNO CH.sub.3 ______________________________________
EXAMPLE 6Starting with the requisite N-aryl-N'-alkyl-N'-(2-methoxycarbonylbenzenesulfonyl)glycineamide and the indicated metal hydride, the procedure of Example 2 is repeated wherein the following compounds are synthesized (product, metal hydride):
3'-methyl-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxide, LiH; 4'-methoxy-3,4-dihydro-2-ethyl-4-oxo-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxide, CaH.sub.2 ; 4'-chloro-3,4-dihydro-2-ethyl-4-oxo-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxide, KH; N-(6-methyl-2-pyridyl)-3,4-dihydro-2-n-propyl-4-oxo-2H-1,2-benzothiazine-3 -carboxamide 1,1-dioxide, NaH; 2'-fluoro-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxide, RbH; 4'-fluoro-3,4-dihydro-2-ethyl-4-oxo-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxide, CaH.sub.2 ; N-(2-thiazolyl)-3,4-dihydro-2-i-propyl-4-oxo-2H-1,2-benzothiazine-3-carbox amide 1,1-dioxide, CsH; N-(4,5-dimethyl-2-thiazolyl)-3,4-dihydro-2-methyl-4-oxo-2H1,2-benzothiazin e-3-carboxamide 1,1-dioxide, BaH.sub.2 ; N-(2-furyl)-3,4-dihydro-2-methyl-4-oxo-2H1,2-benzothiazine-3-carboxamide 1,1-dioxide, CaH.sub.2 ; N-(2-furyl)-3,4-dihydro-2-methyl-4-oxo-2H- 1,2-benzothiazine-3-carboxamide 1,1-dioxide, LiH; 3' -methoxy 3,4-dihydro-2-n-propyl-4-oxo-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxide, KH: 2'-chloro-3,4-dihydro-2-ethyl-4-oxo-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxide, MgH.sub.2 ; N-(2-pyridyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxamid e 1,1-dioxide, RbH: N-(6-methyl-2-pyridyl)-3,4-dihydro-2-ethyl-4-oxo-2H-1,2-benzothiazine-3-ca rboxamide 1,1-dioxide, LiH 4'-methyl-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxide, KH; N-(2-thiazolyl)-3,4-dihydro-2-i-propyl- 4-oxo-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, BaH.sub.2 ; N-(5-methyl-3-isoxazolyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine- 3-carboxamide 1,1-dioxide, CaH.sub.2 ; and N-(5-methyl-3-isoxazolyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine- 3-carboxamide 1,1-dioxide, LiH.
PREPARATION A Benzyloxycarbonylglycineamides1. N-Methyl-N'-benzyloxycarbonyl-N-(2-thiazolyl)glycineamide
(2: R.sub.1 = 2--C.sub.3 H.sub.2 NS; R.sub.2 = CH.sub.3 ; R.sub.3 = CH.sub.3 ; X = H)
to a yellow solution of 9.44 g. (42.3 m moles) of commercially available N-benzyloxycarbonyl-N-methylglycine and 4.8 g. (48 m moles) of 2-aminothiazole in 75 ml. of dry tetrahydrofuran under a nitrogen atmosphere is added dropwise 13 g. (53 m moles) of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in 75 ml. of the same solvent. The resulting reaction mixture is allowed to stir at room temperature for 1 hr. and is then heated under reflux for 2 hrs. The solution is cooled in ice and the resulting solids filtered and dried, 4.6 g., m.p. 203.degree.-205.degree. C.
Anal. Calc'd for C.sub.14 H.sub.15 O.sub.3 N.sub.3 S: C, 55.06; H, 4.59; N, 13.76.
Found: C, 55.02; H, 4.94; N, 13.71.
2. in a similar manner to Preparation A-1, starting with the requisite glycine derivative and aryl amine, the following benzyloxycarbonylglycineamides are synthesized as intermediates:
______________________________________ ##STR7## R.sub.1 R.sub.2 ______________________________________ C.sub.6 H.sub.5 CH.sub.3, C.sub.2 H.sub.5 and n-C.sub.3 H.sub.7 6-CH.sub.3 -2-C.sub.5 H.sub.4 N CH.sub.3, C.sub.2 H.sub.5 and n-C.sub.3 H.sub.7 3-ClC.sub.6 H.sub.4 CH.sub.3 3-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 4-CH.sub.3 OC.sub.6 H.sub.4 CH.sub.3 and C.sub.2 H.sub.5 2-C.sub.4 H.sub.3 O CH.sub.3 4,5-(CH.sub.3).sub.2 C.sub.3 NS CH.sub.3 and n-C.sub.3 H.sub.7 2-ClC.sub.6 H.sub.4 CH.sub.3 and C.sub.2 H.sub.5 4-ClC.sub.6 H.sub.4 CH.sub.3 and C.sub.2 H.sub.5 2-FC.sub.6 H.sub.4 CH.sub.3 2-C.sub.5 H.sub.4 N CH.sub.3, C.sub.2 H.sub.5 and i-C.sub.3 H.sub.7 4-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 2-C.sub.3 H.sub.2 NS C.sub.2 H.sub.5, n-C.sub.3 H.sub.7 and i-C.sub.3 H.sub.7 4-FC.sub.6 H.sub.4 C.sub.2 H.sub.5 3-CH.sub.3 OC.sub.6 H.sub.4 n-C.sub.3 H.sub.7 3-FC.sub.6 H.sub.4 i-C.sub.3 H.sub.7 2-CH.sub.3 OC.sub.6 H.sub.4 i-C.sub.3 H.sub.7 5-CH.sub.3 -3-C.sub.3 HNO CH.sub.3 ______________________________________
PREPARATION B Glycineamides1. N'-Methyl-N-(2-thiazolyl)glycineamide (3: R.sub.1 = CH.sub.3 ; R.sub.2 = 2--C.sub.3 H.sub.2 NS)
To 5 g. of N'-methyl-N'-benzyloxycarbonyl-N-(2-thiazolyl)glycineamide under a nitrogen atmosphere is added slowly with stirring 50 ml. of a 33 percent hydrogen bromide solution in acetic acid. After the vigorous evolution of carbon dioxide has subsided, the reaction mixture is allowed to stir at room temperature overnight. Diethyl ether (275 ml.) is added and the precipitated solids filtered and dried, 5.4 g., m.p. 242.degree.-244.degree. C., dec.
The analytical sample is recrystallized from ethanoldiethyl ether.
Anal. Calc'd for C.sub.6 H.sub.9 ON.sub.3 S.2HBr: C, 21.64; H, 3.33; N, 12.62.
Found: C, 22,36; H, 3.34; N, 12.87.
The free base is generated by treatment of an aqueous solution of the hydrobromide salt with an aqueous sodium hydroxide solution, followed by extraction of the free base into a water-immiscible solvent such as benzene.
2. N'-Alkyl-N-Arylglycineamides
Starting with the requisite intermediate from Preparation A-2 and following the procedure of Preparation B-1, the following intermediate products are prepared:
R.sub.2 NHCH.sub.2 CONHR.sub.1
______________________________________ r.sub.1 r.sub.2 ______________________________________ c.sub.6 h.sub.5 ch.sub.3, c.sub.2 h.sub.5 and n-C.sub.3 H.sub.7 6-CH.sub.3 -2-C.sub.5 H.sub.4 N CH.sub.3, C.sub.2 H.sub.5 and n-C.sub.3 H.sub.7 3-ClC.sub.6 H.sub.4 CH.sub.3 3-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 4-CH.sub.3 OC.sub.6 H.sub.4 CH.sub.3 and C.sub.2 H.sub.5 2-C.sub.4 H.sub.3 O CH.sub.3 4,5-(CH.sub.3).sub.2 C.sub.3 NS CH.sub.3 and n-C.sub.3 H.sub.7 2-ClC.sub.6 H.sub.4 CH.sub.3 and C.sub.2 H.sub.5 4-ClC.sub.6 H.sub.4 CH.sub.3 and C.sub.2 H.sub.5 2-FC.sub.6 H.sub.4 CH.sub.3 and C.sub.2 H.sub.5 2-C.sub.5 H.sub.4 N CH.sub.3, C.sub.2 H.sub.5 and i-C.sub.3 H.sub.7 4-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 2-C.sub.3 H.sub.2 NS C.sub.2 H.sub.5, n-C.sub.3 H.sub.7 and i-C.sub.3 H.sub.7 4-FC.sub.6 H.sub.4 C.sub.2 H.sub.5 3-CH.sub.3 OC.sub.6 H.sub.4 n-C.sub.3 H.sub.7 3-FC.sub.6 H.sub.4 i-C.sub.3 H.sub.7 2-CH.sub.3 OC.sub.6 H.sub.4 i-C.sub.3 H.sub.7 5-CH.sub.3 -3-C.sub.3 HNO CH.sub.3 ______________________________________
PREPARATION C 2-Carboalkoxybenzenesulfonyl Chlorides1. A heavy precipitate resulting from the addition of 85 ml. of 12N hydrochloric acid to 37.8 g. of methyl anthranilate in 50 ml. of cold water is stirred and maintained at 0.degree.-5.degree. C. in an ice bath while 19.0 g. of sodium nitrite in 30 ml. of cold water is added dropwise. The resulting pale yellow solution is stirred for 30 min. at 0.degree.-5.degree. C. and is filtered through a sentered glass filter.
The above filtrate containing the diazonium salt is slowly added dropwise to a solution resulting from the addition of a cold solution of 40 g. of sulfur dioxide in 200 ml. of glacial acetic acid to a cold suspension of 8 g. of cupric chloride in 111 ml. of glacial acetic acid. During the second half of the addition and for 20 min. after the addition is complete, gas evolution is evident.
After stirring the reaction mixture for 1 hr. in the cold, 1.4 l. of ice water is added and the precipitate intermediate product is filtered and dried in vacuo, 9.2 g., m.p. 60.degree.-62.degree. C.
Meerwein, et al., Chem. Ber., 90, 841 (1957) reports a m.p. of 64.degree.-65.degree. C. for this compound which is prepared by a similar procedure.
2. Substituted 2-Carboalkoxybenzenesulfonyl chlorides
Starting with the appropriately substituted anthranilic acid esters which are either known in the chemical literature or readily prepared by methods known to those skilled in the art and employing the procedure of Meerwhein, et al. or that of Preparation C-1, the following sulfonyl chlorides are synthesized:
______________________________________ ##STR8## X R.sub.3 ______________________________________ 4-F CH.sub.3 6-F CH.sub.3 4-Cl CH.sub.3 5-Cl CH.sub.3 6-Cl CH.sub.3 3-CH.sub.3 CH.sub.3 4-CH.sub.3 CH.sub.3 5-CH.sub.3 CH.sub.3 4-CH.sub.3 O CH.sub.3 5-CH.sub.3 CH.sub.3 O CH.sub.3 6-CH.sub.3 O CH.sub.3 H C.sub.2 H.sub.5 H n-C.sub.3 H.sub.7 ______________________________________
PREPARATION D N-Benzensulfonylglycineamides1. N-(2-Thiazolyl)-N'-methyl-N'-(2'-methoxycarbonylbenzene sulfonyl)glycineamide
N'-Methyl-N-(2-thiazolyl)glycineamide, generated from 4.84 g. of the corresponding dihydrobromide salt, in 50 ml. of benzene is treated with 3.41 g. of 2-methoxycarbonylbenzenesulfonyl chloride, and the resulting mixture heated under reflux for 30 hrs. The reaction mixture is cooled and the precipitated solids filtered, washed with benzene and partitioned between water and chloroform. The water layer is extracted several additional times with chloroform, and the chloroform extracts combined and dried over sodium sulfate. The organic solvent is removed in vacuo and the tan residual solid is triturated with hexane and filtered, 640 mg., m.p. 215.degree. C. dec. The analytical sample is recrystallized from methanol, m.p. 216.degree.-218.degree. C. dec.
Anal. Calc'd for C.sub.14 H.sub.15 O.sub.5 N.sub.3 S.sub.2 : C, 45.52; H, 4.09; N, 11.37.
Found: C, 45.02; H, 4.12; N, 11.71.
2. n-aryl-N'-alkyl-(2'-alkoxycarbonylbenzenesulfonyl)glycineamides
Starting with the requisite intermediates from Preparations B and C and employing the procedure of Preparation D-1, the following intermediates are prepared:
______________________________________ ##STR9## X R.sub.1 R.sub.2 R.sub.3 ______________________________________ H C.sub.6 H.sub.5 CH.sub.3 C.sub.2 H.sub.5 H 6-CH.sub.3 -2-C.sub.5 H.sub.3 N CH.sub.3 n-C.sub.3 H.sub.7 H 3-ClC.sub.6 H.sub.4 CH.sub.3 CH.sub.3 4-F C.sub.6 H.sub.5 CH.sub.3 CH.sub.3 4-F 3-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 CH.sub.3 4-F 4-CH.sub.3 OC.sub.6 H.sub.4 C.sub.2 H.sub.5 CH.sub.3 6-F 4-CH.sub.3 OC.sub.6 H.sub.4 CH.sub.3 CH.sub.3 6-F 4-ClC.sub.6 H.sub.4 C.sub.2 H.sub.5 CH.sub.3 6-F 6-CH.sub.3 -2-C.sub.5 H.sub.3 N n-C.sub.3 H.sub.7 CH.sub.3 4-Cl 3-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 CH.sub.3 4-Cl 2-C.sub.3 H.sub.2 NS n-C.sub. 3 H.sub.7 CH.sub.3 4-Cl 3-FC.sub.6 H.sub.4 i-C.sub.3 H.sub.7 CH.sub.3 4-Cl 2-CH.sub.3 OC.sub.6 H.sub.4 i-C.sub.3 H.sub.7 CH.sub.3 5-Cl 2-C.sub.3 H.sub.2 NS CH.sub.3 CH.sub.3 5-Cl 2-C.sub.3 H.sub.2 NS C.sub.2 H.sub.5 CH.sub.3 5-Cl 2-C.sub.5 H.sub.4 N C.sub.2 H.sub.5 CH.sub.3 5-Cl 2-C.sub.5 H.sub.4 N i-C.sub.3 H.sub.7 CH.sub.3 5-Cl 2-C.sub.4 H.sub.3 0 CH.sub.3 CH.sub.3 6-Cl C.sub.6 H.sub.5 CH.sub.3 CH.sub.3 3-CH.sub.3 C.sub.6 H.sub.5 CH.sub.3 CH.sub.3 3-CH.sub.3 4,5-(CH.sub.3).sub.2 -2-C.sub.3 NS CH.sub.3 CH.sub.3 3-CH.sub.3 4,5-(CH.sub.3).sub.2 -2-C.sub.3 NS n-C.sub.3 H.sub.7 CH.sub.3 3-CH.sub.3 4-ClC.sub.6 H.sub.4 C.sub.2 H.sub.5 CH.sub.3 3-CH.sub.3 4-CH.sub.3 OC.sub.6 H.sub.4 CH.sub.3 CH.sub.3 4-CH.sub.3 2-C.sub.3 H.sub.2 NS CH.sub.3 CH.sub.3 4-CH.sub.3 2-C.sub.5 H.sub.4 N C.sub.2 H.sub.5 CH.sub.3 4-CH.sub.3 2-C.sub.4 H.sub. 3 O CH.sub.3 CH.sub.3 4-CH.sub.3 4-CH.sub.3 OC.sub.6 H.sub.4 CH.sub.3 CH.sub.3 4-CH.sub.3 2-C.sub.5 H.sub.4 N i-C.sub.3 H.sub.7 CH.sub.3 5-CH.sub.3 6-CH.sub.3 -2-C.sub.5 H.sub.3 N CH.sub.3 CH.sub.3 5-CH.sub.3 6-CH.sub.3 -2-C.sub.5 H.sub.3 N n-C.sub.3 H.sub.7 CH.sub.3 5-CH.sub.3 3-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 CH.sub.3 5-CH.sub.3 4,5-(CH.sub.3).sub.2 C.sub.3 NS CH.sub.3 CH.sub.3 5-CH.sub.3 C.sub.6 H.sub.5 C.sub.2 H.sub.5 CH.sub.3 4-CH.sub.3 O C.sub.6 H.sub.5 CH.sub.3 CH.sub.3 4-CH.sub.3 O C.sub.6 H.sub.5 C.sub.2 H.sub.5 CH.sub.3 4-CH.sub.3 O C.sub.6 H.sub.5 n-C.sub.3 H.sub.7 CH.sub.3 4-CH.sub.3 O 2-ClC.sub.6 H.sub.4 CH.sub.3 CH.sub.3 4-CH.sub.3 O 2-C.sub.4 H.sub.3 O CH.sub.3 CH.sub.3 5-CH.sub.3 O 3-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 CH.sub.3 5-CH.sub.3 O 2-C.sub.3 H.sub.2 NS n-C.sub.3 H.sub.7 CH.sub.3 5-CH.sub.3 O 2-C.sub.5 H.sub.4 N C.sub.2 H.sub.5 CH.sub.3 5-CH.sub.3 O 6-CH.sub.3 -2-C.sub.5 H.sub.3 N CH.sub.3 CH.sub.3 5-CH.sub.3 O 3-ClC.sub.6 H.sub.4 CH.sub.3 CH.sub.3 6-CH.sub.3 O C.sub.6 H.sub.5 CH.sub.3 CH.sub.3 6-CH.sub.3 O C.sub.6 H.sub.5 C.sub.2 H.sub.5 CH.sub.3 6-CH.sub.3 O 4-CH.sub.3 OC.sub.6 H.sub.4 CH.sub.3 CH.sub.3 6-CH.sub.3 O 4-ClC.sub.6 H.sub.4 CH.sub.3 CH.sub.3 H 3-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 CH.sub.3 H 4-CH.sub.3 OC.sub.6 H.sub.4 C.sub.2 H.sub.5 CH.sub.3 5-Cl 5-CH.sub.3 -3-C.sub.3 HNO CH.sub.3 CH.sub.3 4-CH.sub.3 5-CH.sub.3 -3-C.sub.3 HNO CH.sub.3 CH.sub.3 4-CH.sub.3 O 5-CH.sub.3 -3-C.sub. 3 HNO CH.sub.3 CH.sub.3 H 5-CH.sub.3 -3-C.sub.3 HNO CH.sub.3 CH.sub.3 H 4-ClC.sub.6 H.sub.4 C.sub.2 H.sub.5 CH.sub.3 H 6-CH.sub.3 -2-C.sub.5 H.sub.3 N n-C.sub.3 H.sub.7 CH.sub.3 H 2-FC.sub.6 H.sub.4 CH.sub.3 CH.sub. 3 H 4-FC.sub.6 H.sub.4 C.sub.2 H.sub.5 CH.sub.3 H 2-C.sub.3 H.sub.2 NS i-C.sub.3 H.sub.7 CH.sub.3 H 4,5-(CH.sub.3).sub.2 -2-C.sub.3 NS CH.sub.3 CH.sub.3 H 2-C.sub.4 H.sub.3 O CH.sub.3 CH.sub.3 H 3-CH.sub.3 OC.sub.6 H.sub.4 n-C.sub.3 H.sub.7 CH.sub.3 H 2-ClC.sub.6 H.sub.4 C.sub.2 H.sub.5 CH.sub.3 H 2-C.sub.5 H.sub.4 N CH.sub.3 CH.sub.3 H 6-CH.sub.3 -2-C.sub.5 H.sub.3 N C.sub.2 H.sub.5 CH.sub.3 H 4-CH.sub.3 C.sub.6 H.sub.4 CH.sub.3 CH.sub.3 ______________________________________
PREPARATION E Metal HydridesThe metal hydrides utilized in the present process are either commercially available or are prepared by literature procedures, Moeller, "Inorganic Chemistry," John Wiley % Sons, New York, New York 1959.
Claims
- R.sub.2 is alkyl containing from 1 to 3 carbon atoms; and
- X is
C..]..[.2. The process of claim 1 wherein the metal hydride is sodium hydride..]..[.3. The process of claim 2 wherein the solvent is tetrahydrofuran..]..[.4. The process of claim 3 wherein X is hydrogen, and R.sub.2 and R.sub.3 are each methyl..]..[.5. The process of claim 4 wherein R.sub.1 is phenyl..]..[.6. The process of claim 4 wherein R.sub.1 is 2-thiazolyl..]..[.7. The process of claim 4 wherein R.sub.1 is 6-methyl-2-pyridyl..]..[.8. The process of claim 4 wherein R.sub.1 is 2-pyridyl..]..Iadd. 9. A compound of the formula
Type: Grant
Filed: Mar 23, 1977
Date of Patent: Jun 13, 1978
Assignee: Pfizer Inc. (New York, NY)
Inventor: Joseph G. Lombardino (Niantic, CT)
Primary Examiner: John M. Ford
Law Firm: Connolly and Hutz
Application Number: 5/780,312
International Classification: C07D27744; C07D21375; C07D27300;